An Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of CCX168 in Subjects with IgA Nephropathy on Stable RAAS Blockade
Status
RECRUITING
Investigator(s)
Richard Lafayette, MD
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
RECRUITING
| Notice of Nondiscrimination ©2022 Stanford Health Care. All Rights Reserved